Authors’ reply to Schaffalitzky de Muckadell and colleague’s Comment on “Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017”

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Saf
Main Authors: Ehlken, Birgit, Nathell, Lennart, Gohlke, Annegret, Bocuk, Derya, Toussi, Massoud, Wohlfeil, Stefan
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Letter to the Editor
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6475511/
https://ncbi.nlm.nih.gov/pubmed/30937851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-019-00815-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados